KRM22 plc
("KRM22", the "Group" and the "Company")
AUDITED RESULTS STATEMENT FOR
THE YEAR ENDED 31 DECEMBER 2023
KRM22 plc (AIM: KRM.L), the technology and software company focused on risk management
in capital markets, announces its audited results for the
year ended 31 December 2023 ("2023", the "Year").
Financial highlights
· Annualised
Recurring Revenue (ARR)[1] as at 31 December 2023 of £5.4m (2022:
£4.8m as reported, £4.6m at constant FX rate) - growth of 17.4% at
constant FX rate
o New contracted ARR in 2023 of
£1.1m (2022: £1.3m)
o Total ARR attributable to the
relationship with Trading Technologies International, Inc. ("TT")
of £0.4m (2022: £0.1m)
· Total revenue
recognised of £5.3m (2022: £4.3m) - growth of 23.3%
· Adjusted EBITDA
loss[2] of £1.4m
(2022: loss of £1.7m)
· Loss before tax of
£4.9m (2022: loss of £3.3m)
· Gross cash as at
31 December 2023 of £0.9m (2022: £1.9m)
· New £5.0m
convertible loan provided by TT, of which £4.5m was drawn down in
the year, to replace the previous Kestrel £3.0m convertible loan
that was due to mature in September 2023
Operational highlights
·
12 new ARR contracts signed in the year including
7 new customers
·
First sales of Limits Manager product generated
through the TT sales channel
·
42 institutional customers as at 31 December
2023
Post
year-end events
·
Growth in ARR to £6.0m as at the date of this
report
·
New Limits Manager product contract win worth
£0.6m over three years with a major Futures Commission Merchant
("FCM"), one of the industry's top 15 largest FCMs
·
Group restructure and rationalisation to implement
a focused cost savings programme, with annual cost savings of
£1.2m
·
Board changes announced on 7 March 2024 with
appointment of Dan Carter as CEO and Garry Jones as Non-Executive
Chairman, replacing Stephen Casner and Keith Todd respectively,
with Keith Todd remaining on the Board as Executive
Director
Garry Jones, Non-Executive Chairman of KRM22,
commented:
"2023 was another year of growth for
KRM22, with increases in ARR and in year recognised revenue.
This momentum has continued into 2024 with further increases in ARR
to £6.0m. The product suite, team and strong pipeline of
sales opportunities, together with the cost savings plan and Board
changes announced in February and March 2024 respectively, mean
that KRM22 has never been in a better position to deliver growth
and become a cash positive business in due course."
[1] Annualised Recurring Revenue (ARR) is the value of
contracted Software-as-a-Service (SaaS) revenue normalised to a one
year period and excludes one-time fees.
[2] Adjusted EBITDA is the reported loss for the year, adjusted
for recurring non-monetary costs including depreciation,
amortisation, unrealised foreign exchange (loss)/gain and
share-based payment (credit)/charges and non-recurring costs, both
monetary and non-monetary, including impairment of intangible
assets, profit on disposal of tangible/intangible assets and
acquisition, deferred consideration write back, gain on
extinguishment of debt and acquisition, funding and debt related
costs.
For further information please
contact:
KRM22 plc
InvestorRelations@krm22.com
Garry Jones, Non-Executive
Chairman
Dan Cater, CEO
Kim Suter, CFO
Cavendish Capital Markets Limited
(Nominated Adviser and Broker)
+44 (0)20 7220
0500
Carl Holmes / George Dollemore
(Corporate Finance)
Sunila de Silva (ECM)
The information contained
within this announcement was deemed by the Company to constitute
inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 as it forms part of UK domestic law by virtue of
the European Union (Withdrawal) Act 2018 as amended. With the
publication of this announcement via a Regulatory Information
Service, this inside information is now considered to be in the
public domain.
About KRM22 plc
KRM22 is a closed-ended investment
company which listed on AIM on 30 April 2018. The Company has
been established with the objective of creating value for its
investors through the investment in, and subsequent growth and
development of, target companies in the technology and software
sector, with a focus on risk management in capital
markets.
Through its investments and the
Global Risk Platform, KRM22 helps capital market companies reduce
the cost and complexity of risk management. The Global Risk
Platform provides applications to help address firms' trading and
corporate risk challenges and to manage their entire enterprise
risk profile.
Capital markets companies' partner
with KRM22 to optimise risk management systems and
processes, improving profitability and expanding opportunities
to increase portfolio returns by leveraging risk as
alpha.
KRM22 plc is listed on AIM and the
Group is headquartered in London, with offices in several of the
world's major financial centres.
See more about KRM22
at KRM22.com.
CHAIRMAN'S STATEMENT
2023 was another year of growth for
KRM22, with Annual Recurring Revenue ("ARR") continuing to achieve
a new high of £5.4m, a 17.4% increase on 2022 at constant FX rates,
as the business added more customers and further developed its
broad product offering. Twelve new ARR contracts were signed
during 2023 including seven new customers.
Continued market volatility and
turbulent geopolitical conditions have naturally resulted in some
conservatism from companies throughout the year when assessing
capital expenditure on new systems and services. It is
exactly these conditions that our risk management products are
built for and can add real value, transparency and security in
uncertain times. We continue to be progressing with
extensions to services for existing customers, whilst pushing hard
to add new Tier one financial institutions to our customer
portfolio.
Our product range of Limits Manager,
Risk Manager, Market Surveillance and Risk Cockpit can be utilised
individually, or in conjunction with each other, to provide a
complete range of risk management services.
In March 2024, we made some internal
changes and appointed Dan Carter as our new CEO. Dan has been
at KRM22 since its inception and has vast experience in the
technology services industry. I have every confidence that
Dan and the management team will drive and accelerate our business
to new heights. I am also honoured to have been appointed as
KRM22's chairman at the same time, and look forward to the
challenges ahead. I would like to take this opportunity to
recognise Stephen Casner and Keith Todd, our predecessors as CEO
and Chairman respectively, for all of their contributions to the
Company since IPO just over six years ago.
The Board and I also wish to thank
our loyal customers and investors for their continued commitment to
our long-term vision of delivering high quality products and
services to the capital markets and derivatives risk
community. The quality of our customers and their importance
to the traded markets gives us much confidence that we are hitting
the mark with industry professionals, who rely on KRM22's products
and services to add value to their business.
I also want to congratulate the
entire KRM22 team for another year of progress, and to recognise
their continued hard work and loyalty to the Company.
I look forward to further growth in
2024, a continued increase in ARR, and becoming a cash generative
business in due course. KRM22 has never been in a better
position as we progress through 2024 and beyond.
Garry Jones
Non-Executive Chairman
CEO'S REPORT
I am delighted to have been appointed
CEO of KRM22 in March 2024. The opportunity that KRM22 has to
be the market leader of risk technology to the capital markets
industry is incredibly exciting. We have very strong
foundations in place, implemented under the leadership of Keith
Todd and Stephen Casner, a strong product offering and a motivated
and ambitious team. I have been at KRM22 since our inception
in 2018, and in my former roles in the Sales and Customer Services
teams, have seen first hand how KRM22 can satisfy our customers
needs and deliver first class technology to the
industry.
Revenue growth
KRM22 continued to make great
progress during 2023 with continuing growth in annualised recurring
revenue ("ARR") year on year with the goal of becoming a £10.0m ARR
business firmly in our sights. The value behind the Global
Risk Platform, and the ability to integrate various aspects of a
firms risk is starting to be leveraged by firms. At 31
December 2023, we had six of the top 15 Futures Commissions
Merchants ("FCMs") in the world using our Limits Manager
product. The Limits Manager product has embedded itself as a
true market leader and is providing firms with a much more
efficient way of managing trading limits whilst at the same time
giving firms a full audit of changes made. As we progress
through 2024 we anticipate the Risk Manager product to become
another industry standard and achieve similar demand and success as
Limits Manager has before it, allowing firms to manage and control
risk in complete sync.
In 2023 we continued to grow ARR
through our two distinct sales "channels" - our direct sales team
as well as the product distribution agreements with various
distributors including Trading Technologies International, Inc.
("TT"). KRM22 added new ARR in 2023 of £1.1m with £0.9m from
direct sales and £0.2m from the TT sales channel. The growth
in ARR was primarily driven by sales of Market Surveillance (42%),
Limits Manager (21%) and Risk Manager (21%), which incorporates the
legacy functionality from the At-Trade P&L and Post-Trade
Stress products.
The Customer Services team, made up
of industry experts who have many years of experience between them,
continue to ensure our service levels are of the highest quality
and thus customer churn is kept to manageable levels.
The partnership with TT continues to
go from strength to strength from a sales and revenue
perspective. The TT distribution agreement allows the Limits
Manager product to be deployed to their customers on their platform
without the timely and burdensome vendor onboarding processes that
KRM22 experiences as a new vendor, thus helping to reduce the
length of sales cycles. In addition to revenue generated
through the distribution agreement with TT, the partnership has
also provided other revenue opportunities for KRM22 with both ARR
and non-recurring revenue for specific projects, both internal and
external to TT.
Products
In 2023 we simplified KRM22's product
offering under the two key distinct areas of risk: Trading Risk,
covering the Limits Manager and Risk Manager products, and
Compliance Risk, covering the Risk Cockpit and Market Surveillance
products.
Limits
Manager
Having been launched in early 2022,
2023 saw the continued development of Limits Manager with the
addition of more user functionality which benefits both the
execution services and risk management teams that use the product,
and therefore created further operational efficiencies for those
using the product. Automation workflows have been delivered
and firms are beginning to automate limit change requests that meet
specific conditions when raised. As we look ahead to 2024 we
will continue to develop more reporting functions for the Limits
Manager product to enhance visibility and further user
understanding of what is happening with their limit change
processes.
Risk
Manager
When KRM22 launched in 2018, the goal
and investment strategy was to bring the various aspects of risk
management together in one place and 2023 saw us invest heavily in
the development of Risk Manager, bringing real-time P&L,
Margin, Stress scenario analysis and VaR together in one
product. The Risk Manager product also allows time series
analysis of these key data points showing key trend analysis to the
user when reviewing the account, or making limit change approval
decisions. We will continue to invest in the product as we
migrate existing customers using the legacy At-Trade and Post-Trade
products onto Risk Manager whilst also delivering the product to
new customers.
Integration of Limits Manager
and Risk Manager
As we progress through 2024, KRM22 is
excited to bring the integration of the Limits Manager and Risk
Manager products into production. This integration will allow
risk managers the ability to review key risk metrics from Risk
Manager and display it alongside the limit changes raised by a
client within Limits Manager. When the risk team within the
financial institution approves the change, these values will be
stored in the audit trail - a crucial view of what standing the
account was in and why the decision was made at that time.
This will provide risk teams with more visibility and information
in real-time when making these key decisions.
Market
Surveillance
The Market Surveillance product
continues to adapt with new alerts, including Spoofing by Order
Depth, Cross Trades and Gilt Closing alongside key functional
changes. We now have over 80 alert types available to
customers in the application. In 2023 KRM22 signed an
agreement with TT to integrate Score, TT's AI/ML surveillance
application, with KRM22's Market Surveillance product, which is a
human calibrated alerting tool, to allow compliance officers to
ensure their calibrations are valid. The planned
release date for this integrated product is late 2024 for TT to
market and sell directly. The project has already generated
ARR and non-recurring revenue for KRM22 and the integrated product
is expected to generate further revenue for KRM22 once product
sales crystalise for TT though a revenue share model.
Outlook
We have continued to make good
progress in the year towards our target of becoming a £10.0m ARR
business with net ARR growth in 2023 of 17.4% and the addition of
seven new customers using our products. As of the date of
this report, the use of the Limits Manager product by seven of the
top 15 FCMs in the world demonstrates that there is demand for such
product and that it, together with the Risk Manager product, has
the ability to become the industry standard for FCMs.
The team is experienced, energised
and ready to grow the business and improve on the results reported
in 2023 as we continue the journey towards a £10.0m ARR business
generating positive EBITDA and cashflows. The pipeline of
sales opportunities is strong and the reorganisation of our
workforce in early 2024 will help us manage the cost base of the
business as we look towards the move to positive adjusted EBITDA
and cashflows.
Dan Carter
CEO
CFO'S REPORT
KRM22's financial results for the
year ended 31 December 2023 has seen a continuation of the
financial turnaround initially reported in the prior year, with
growth of 23.3% in total revenue recognised to £5.3m from £4.3m
reported for the year ended 31 December 2022.
ARR continued to increase, with ARR
exceeding £5.0m for the first time in 2023 since KRM22's inception
in 2018, to end the year at £5.4m from £4.6m at 31 December 2022 at
constant FX rates - a year-on-year increase of
17.4%.
Adjusted EBITDA loss reported for
2023 was £1.4m, an improvement on the £1.7m reported in 2022.
This growth was set against continued global economic uncertainty
and extended sales cycles.
Profit and Loss
Total
revenue
Revenue recognised for the year to 31
December 2023 was £5.3m (2022: £4.3m), an increase of 23.3%
compared with the prior year, with 90.6% (2022: 92.3%) of total
revenue generated from recurring customer contracts.
Non-recurring revenue for the year ended 31 December 2023 totalled
£0.5m (2022: £0.3m) and related principally to customer
implementations, product development and proof of concept
work.
Recurring
revenue
ARR is a key metric and KPI for KRM22
and as at 31 December 2023, ARR had increased by 17.4% to £5.4m
(2022: £4.8m as reported, £4.6m at constant FX rates), a net
increase of £0.8m at constant FX rates (2022: net increase of
£1.0m).
New contracted ARR in the year
totalled £1.1m (2022: £1.3m) of which £0.6m (2022: £0.7m) was from
seven new customers and £0.5m (2022: £0.6m) was generated from
existing customers. Included within the £0.6m of new ARR from
new customers was £0.2m (2022: £nil) of ARR generated from sales of
the Limits Manager product under the distribution agreement which
KRM22 has with TT. The £0.5m of new ARR generated from
existing customers was a combination of these existing customers
purchasing additional products and contractual renewals for
existing products, with an increase in ARR and extensions of
contractual terms.
The amount of ARR generated through
partner products and services, primarily through data and news
feeds, with minimal margin to KRM22, accounted for 4.6% (2022:
6.9%).
Total churn in ARR for the year was
£0.4m (2022: £0.6m), from three institutional customers, of which
£0.1m was anticipated as it related to a customer acquired through
the acquisition of Object+ in 2019 using a bespoke product that
does not form part of the current product offering. A further
£0.1m of churn was from a customer directly impacted by the SVB
collapse in March 2023. The third customer, with churn of
£0.1m, related to data feeds which, whilst impacting ARR and
revenue recognition, had minimal profit margin and so the effect on
the operating loss is £nil.
Gross
profit
Gross profit for the year to 31
December 2023 was £4.1m (2022: £3.3m). There was a small
increase in gross profit margin to 78% compared to the prior year
margin of 77% which was due to an improvement in foreign currency
rates, compared with the prior year when there was volatility and
adverse movements, with a significant proportion of the Group's
cost of sales being Amazon Web Services server costs which are
invoiced in US dollars.
Capitalised
development
A total of £1.1m (2022: £0.8m) of
development was capitalised in the year to 31 December 2023.
Capitalised development is amortised over three years.
Adjusted
EBITDA
Adjusted EBITDA is the key metric
that the Company considers in order to understand the
cash-profitability of the business. This is due in particular
to the non-cash items that impact the Income Statement under IFRS
accounting, such as non-cash share-based payment
charges.
Adjusted EBITDA for the year to 31
December 2023 was a £1.4m loss (2022: loss of £1.7m). Whilst
the adjusted EBITDA loss reported for the year is a £0.3m
improvement on the prior year, this reduction is not proportional
to the increase in total revenue recognised in the year compared
with the prior year and this was due to the increase in
administrative expenses.
The increase in administrative costs
was primarily driven by two factors. Firstly, in 2022 KRM22
used the investment proceeds from TT's investment in KRM22 in
December 2021 to invest in Revenue, Customer Services and
Development resource to help drive the business forward and the
timing of this new resource joining KRM22 occurred throughout
2022. Administrative costs for the year ended 31 December
2023 therefore includes a full year of increased staff costs
compared with the prior year. In addition to the
aforementioned investment in resource, the rate of inflation in
2022 and 2023 meant that staff salary reviews, which are completed
on an annual basis in the first quarter of each year, resulted in a
significantly higher average pay increase in 2023 compared to
2022. The average pay increase in 2023, whilst being higher
than 2022, was not matched to the rate of inflation.
A reconciliation of Adjusted EBITDA
loss to the reported operating loss is provided as
follows:
|
2023
£'m
|
2022
£'m
|
Adjusted EBITDA loss
|
(1.4)
|
(1.7)
|
Depreciation and
amortisation
|
(1.3)
|
(1.6)
|
Impairment of intangible
assets
|
(1.6)
|
-
|
Unrealised FX
(losses)/gain
|
(0.5)
|
0.8
|
Deferred consideration write
back
|
0.1
|
-
|
Acquisition and debt
expenses
|
0.0
|
-
|
Gain on extinguishment of
debt
|
0.1
|
-
|
Shared-based payment
(credit)/expense
|
0.1
|
(0.1)
|
Operating loss
|
(4.5)
|
(2.6)
|
Operating
loss
Reported operating loss for the year
to 31 December 2023 was £4.5m (2022: loss of £2.6m) and includes an
impairment charge of £1.6m primarily related to a revision in the
estimated recoverable amount of goodwill using a value-in-use model
by projecting cashflows for future years using different inputs to
the model compared with prior years.
Finance
charges
Net finance expense in the year was
£0.4m (2022: £0.6m) and includes:
·
Loan interest of £0.4m (2022: £0.3m);
·
IFRS16 lease liability interest of £0.0m (2022:
£0.1m); and
·
Derivative financial instrument fair value
adjustment of £0.0m (2022: £0.2m).
Taxation
The tax credit in the year was £0.3m
(2022: credit of £0.2m) which includes a £0.2m (2022: £0.1m)
R&D tax credit received.
Financial position
Assets
The cash balance as at 31 December
2023 was £0.9m (2022: £1.9m).
Current assets at 31 December 2023
include trade and other receivables of £1.1m (2022:
£1.5m).
Non-current assets were £5.8m (2022:
£7.8m) relating principally to: £4.2m for goodwill and assets
acquired (2022: £6.1m), £1.4m (2022: £1.3m) for capitalised
development costs, and £0.1m for right of use assets recognised
under IFRS16 (2022: £0.4m).
Liabilities
As at 31 December 2023, our principal
liabilities were:
·
£4.5m convertible loan owed to TT plus accrued
interest of £0.2m.
·
£0.7m (US$0.9m) deferred consideration for earn
out payments for the acquisition of Object+. The deferred
consideration can be satisfied in either cash or Company Ordinary
Shares in KRM22 at the Company's discretion.
·
£0.4m for the right of use assets relating to all
future payments of leased-office rentals under IFRS16 'Leases'
whereby such lease payments are provided for at today's
value. KRM22 has one remaining lease in London which expires
in 2024.
·
£2.2m of deferred revenue; contracted and paid
services that will be released in a future period.
Investors
As an AIM quoted business, a large
proportion of KRM22's shareholders are professional investment
funds. In addition, the Directors together owned 3,764,958
shares at the year end, representing 10.6% of the Company's issued
share capital.
Funding
On 17 June 2023, KRM22 entered into
an agreement for a new three year £5.0m convertible loan facility
(the "TT Convertible Loan") with TT, the Company's largest
shareholder. At 31 December 2023, KRM22 had drawn down £4.5m
of the total facility amount and these proceeds were used to
replace the Company's existing convertible loan (the "Kestrel
Convertible Loan") with Kestrel Partners LLP. The outstanding
balance of the Kestrel Convertible Loan, inclusive of principal and
accrued interest was £3.1m.
The interest rate payable on the TT
Convertible Loan is the average 90 day Secured Overnight Financing
Rate ("SOFR") and a margin of 5.5%, subject to a minimum aggregate
percentage rate per annum of 9.25%. Interest is payable
quarterly in arrears however KRM22 has the ability to defer
interest payments in the initial 18 months (the "Initial Interest
Period"), with the total deferred interest in the Initial Interest
Period being paid in two equal instalments on the calendar quarters
ending after the 18th and 21st month
anniversary of the facility, i.e. 31 December 2024 and 31 March
2025.
Under the terms of the TT Convertible
Loan agreement dated 17 June 2023 (the "TT Loan Agreement"), any
amounts drawn down from the TT Convertible Loan could be converted
into new Ordinary Shares in the Company by TT at any time at the
lowest conversion price of: £0.46, the volume weighted average
price of the Company's ordinary shares for the three month period
prior to service of conversion notice; or the lowest daily closing
price for the 30 completed calendar days prior to service of
conversion notice. On 1 July 2023, the TT Loan Agreement was
amended to remove the variability of the conversion price and
replace with a fixed conversion price of £0.46. TT has the
right to prevent any conversion which would trigger a Rule 9 event
under the Takeover Code.
The TT Convertible Loan is secured on
certain KRM22 assets and includes covenants based on the Group's
financial performance including ARR, revenue recognition and
solvency.
Use
of cash in the year
Our net cash outflow in the year was
£1.0m, which included £4.5m draw down receipts from the TT
Convertible Loan, of which £3.0m was used to settle the Kestrel
Convertible Loan principal, £1.1m was used for capitalised
development, £0.2m was used to pay interest on the Kestrel
Convertible Loan and the balance was used to provide working
capital for KRM22.
Going concern
The financial statements have been
prepared on a going concern basis based on a range of cashflow
forecasts and scenarios covering a period of at least twelve months
from the date of this report. The time to close new customers
and the value of each customer, which are deemed individually as
high value and low volume in nature, is key to the forecast being
achieved. Even if the forecast is achieved, there remains a
material uncertainty around KRM22 operating within the financial
covenants associated with the TT Convertible Loan. The Board
have received a letter of support from TT that they would be
willing to enter into discussions with KRM22 around amending the
terms of the TT Convertible Loan to ensure that KRM22 does not
breach the financial covenants. Further analysis of KRM22's
going concern position is detailed in
note 2 (notes to
the financial information).
Shareholdings and Earnings per share
As at 31 December 2023, KRM22 had
35,666,336 shares in issue and this was also the undiluted weighted
average number of shares for the period. The resulting
Earning per Share ("EPS") is a 13.0p loss per share (2022: loss of
8.7p). Due to the loss made by the Company in the year, the
diluted EPS is the same as EPS.
Conclusion
In 2023, KRM22 has continued to grow
with recognised revenue increasing by 23.3% to £5.3m, ARR
increasing to £5.4m which, as at the date of this report, has
further increased to £6.0m. Whilst administrative costs
increased in 2023 compared with the prior year, the Board took
action in early 2024 to review the underlying cost base of the
business and have since implemented a focused cost savings
programme to generate annual cost savings of approximately
£1.2m. This cost savings programme, together with significant
sales pipeline opportunities, both from direct selling
opportunities and through the TT distribution agreement, will
improve the adjusted EBITDA position going forward and accelerate
the Company's path to profitability.
Kim Suter
CFO
Consolidated income statement
and statement of comprehensive income
for the year ended 31
December 2023
|
Note
|
2023
£'000
|
2022
£'000
|
Revenue Cost of
sales
|
3
|
5,266
(1,145)
|
4,273
(955)
|
Gross profit
Other operating income
Administrative expenses
|
|
4,121
142
(8,788)
|
3,318
131
(6,077)
|
Operating loss before interest,
taxation, depreciation, amortisation, share based payment and
exceptional items ('Adjusted EBITDA')
|
|
(1,399)
|
(1,684)
|
|
Depreciation and
amortisation
|
|
(1,298)
|
(1,637)
|
|
Impairment of intangible
assets
|
|
(1,593)
|
-
|
|
Profit on disposal of
tangible/intangible assets
|
|
-
|
14
|
|
Deferred consideration write
back
|
|
115
|
-
|
|
Gain on extinguishment of debt
(net)
|
|
127
|
-
|
|
Unrealised foreign exchange
(loss)/gain
|
|
(539)
|
812
|
|
Acquisition, funding and debt
related expenses
|
|
(38)
|
-
|
|
Share based payment
credit/(charge)
|
|
100
|
(133)
|
|
Operating loss
|
|
(4,525)
|
(2,628)
|
|
Finance charge (net)
|
|
(353)
|
(641)
|
|
Loss before taxation
|
|
(4,878)
|
(3,269)
|
Taxation
credit
|
|
259
|
168
|
Loss for the year
|
|
(4,619)
|
(3,101)
|
Loss for the year attributable to:
|
|
|
|
Equity shareholders of the
parent
|
|
(4,619)
|
(3,101)
|
|
|
(4,619)
|
(3,101)
|
Other comprehensive income
Item that may be reclassified
subsequently to profit and loss:
|
|
|
|
Exchange gain/(loss) on translation
of foreign operations
|
|
334
|
(563)
|
Total comprehensive loss for the year
|
|
(4,285)
|
(3,664)
|
Total comprehensive loss for the year attributable
to:
|
|
|
|
Equity shareholders of the
parent
|
|
(4,285)
|
(3,664)
|
|
|
(4,285)
|
(3,664)
|
Loss per ordinary share
|
|
|
|
Basic
losses per share
|
4
|
(13.0p)
|
(8.7p)
|
Diluted losses per share
|
4
|
(13.0p)
|
(8.7p)
|
Consolidated statement of
financial position
at 31 December
2023
|
Note
|
2023
£'000
|
2022
£'000
|
Non-current assets
|
|
|
|
Goodwill
|
5
|
3,516
|
5,167
|
Other intangible assets
|
5
|
2,105
|
2,244
|
Property,
plant and equipment
|
|
21
|
11
|
Right of use assets
|
|
136
|
369
|
|
|
5,778
|
7,791
|
Current assets
|
|
|
|
Trade and
other receivables
|
|
1,142
|
1,462
|
Cash and
cash equivalents
|
|
886
|
1,900
|
|
|
2,028
|
3,362
|
Total assets
|
|
7,806
|
11,153
|
Current liabilities
|
|
|
|
Trade and
other payables
|
|
3,900
|
3,853
|
Lease liabilities
|
|
369
|
493
|
Loans and
borrowings
|
|
391
|
2,974
|
Derivative financial liability
|
|
196
|
255
|
|
|
4,856
|
7,575
|
Net current liabilities
|
|
(2,828)
|
(4,213)
|
Non-current liabilities
|
|
|
|
Trade and
other payables
|
|
-
|
30
|
Lease liabilities
|
|
-
|
122
|
Loans and
borrowings
|
|
3,887
|
-
|
Deferred
tax liability
|
|
164
|
245
|
|
|
4,051
|
397
|
Total liabilities
|
|
8,907
|
7,972
|
Net (liabilities)/assets
|
|
(1,101)
|
3,181
|
Equity
|
|
|
|
Share
capital
|
|
3,567
|
3,567
|
Share premium
|
|
20,517
|
20,517
|
Merger reserve
|
|
(190)
|
(190)
|
Convertible debt reserve
|
|
327
|
224
|
Foreign exchange reserve
|
|
(114)
|
(448)
|
Share-based payment reserve
|
|
2,945
|
3,045
|
Retained deficit
|
|
(28,153)
|
(23,534)
|
Total equity
|
|
1,101
|
3,181
|
Consolidated statement of
cash flows
for the year ended 31
December 2023
|
2023
£'000
|
2022
£'000
|
Cash flows from operating activities
|
|
|
Loss for the year
|
(4,619)
|
(3,101)
|
Adjustments for:
|
|
|
Tax credit
|
(259)
|
(168)
|
Net finance expense
|
353
|
641
|
Amortisation of intangible
assets
|
1,059
|
1,324
|
Depreciation of property, plant and
equipment and right of use assets
|
239
|
313
|
Impairment of intangible
assets
|
1,593
|
-
|
Profit on disposal of
intangible/tangible assets
|
-
|
(14)
|
Deferred consideration write
back
|
(115)
|
-
|
Gain on extinguishment of
debt
|
(127)
|
-
|
Unrealised loss/(gain) on non-GBP
denominated loans
|
539
|
(812)
|
Equity-settled Share-based payment
(credit)/expense
|
(100)
|
133
|
Income taxes received
|
186
|
97
|
|
(1,251)
|
(1,587)
|
Decrease/(increase) in trade and
other receivables
|
320
|
(721)
|
Increase in trade and other
payables
|
52
|
187
|
Net cash flows used in operating activities
|
(879)
|
(2,121)
|
Cash flows from investing activities
|
|
|
Acquisition deferred consideration
payment
|
(43)
|
-
|
Purchase of intangible
assets
|
(1,105)
|
(840)
|
Purchase of property, plant and
equipment
|
(16)
|
(8)
|
Net cash used in investing activities
|
(1,164)
|
(848)
|
Cash flows from financing activities
|
|
|
Lease payments principal
|
(232)
|
(217)
|
Lease payments interest
|
(18)
|
(33)
|
Receipts from borrowings
|
4,500
|
-
|
Interest paid
|
(208)
|
(285)
|
Repayments of borrowings
|
(3,000)
|
-
|
Net cash from/(used in) financing activities
|
1,042
|
(535)
|
Net decrease in cash and cash equivalents
|
(1,001)
|
(3,504)
|
Cash and cash equivalents at
beginning of year
|
1,900
|
5,362
|
Effect of foreign exchange rate
changes
|
(13)
|
42
|
Cash and cash equivalents at end of year
|
886
|
1,900
|
Consolidated statement of
changes in equity
for the year ended 31
December 2023
|
|
|
|
|
|
|
|
|
|
Ordinary
shares
|
Share premium
|
Merger
reserve
|
Convertible debt reserve
|
Foreign
exchange reserve
|
Share
based payment reserve
|
Retained
losses
|
Total
equity
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
At
1 January 2022
|
3,567
|
20,517
|
(190)
|
224
|
115
|
2,912
|
(20,433)
|
6,712
|
Loss for
the year
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,101)
|
(3,101)
|
Other
comprehensive loss
|
-
|
-
|
-
|
-
|
(563)
|
-
|
-
|
(563)
|
Total comprehensive loss
|
-
|
-
|
-
|
-
|
(563)
|
-
|
(3,101)
|
(3,664)
|
Share-based payments
|
-
|
-
|
-
|
-
|
-
|
133
|
-
|
133
|
At
31 December 2022
|
3,567
|
20,517
|
(190)
|
224
|
(448)
|
3,045
|
(23,534)
|
3,181
|
Loss for the year
|
-
|
-
|
-
|
-
|
-
|
-
|
(4,619)
|
(4,619)
|
Other comprehensive gain
|
-
|
-
|
-
|
-
|
334
|
-
|
-
|
334
|
Total comprehensive
gain/(loss)
|
-
|
-
|
-
|
-
|
334
|
-
|
(4,619)
|
(4,285)
|
Convertible debt option
|
-
|
-
|
-
|
103
|
-
|
-
|
-
|
103
|
Share-based payments
|
-
|
-
|
-
|
-
|
-
|
(100)
|
-
|
(100)
|
At
31 December 2023
|
3,567
|
20,517
|
(190)
|
327
|
(114)
|
2,945
|
(28,153)
|
(1,101)
|
Notes to the financial
information
1. Accounting
basis
The financial information set out
in this document does not constitute the Group's statutory accounts
for the years ended 31 December 2022 or 2023. Statutory
accounts for the years ended 31 December 2022 and 31 December 2023,
which were approved by the Directors on 21 May 2024, have been
reported on by the Independent Auditors. The Independent
Auditor's Reports on the Annual Report and Financial Statements for
each of 2022 and 2023 were unqualified, did draw attention to a
matter by way of emphasis, being going concern and did
not contain a statement under 498(2) or 498(3) of the Companies Act
2006.
Statutory accounts for the year
ended 31 December 2022 have been filed with the Registrar of
Companies. The statutory accounts for the year ended 31
December 2023 will be delivered to the Registrar of Companies in
due course and will be posted to shareholders shortly, and
thereafter will be available from the Company's registered office
at 5 Ireland Yard, London, England, EC4V 5EH and from the Company's
website: http://krm22.com/investors/
The financial information set out
in these results has been prepared using the recognition and
measurement principles of International Accounting Standards,
International Financial Reporting Standards and Interpretations in
conformity with the requirements of the Companies Act 2006.
The accounting policies adopted in these results have been
consistently applied to all the years presented and are consistent
with the policies used in the preparation of the financial
statements for the year ended 31 December 2023, except for those
that relate to new standards and interpretations effective for the
first time for periods beginning on (or after) 1 January
2022. There are deemed to be no new standards, amendments and
interpretations to existing standards, which have been adopted by
the Group, that have had a material impact on the financial
statements.
The Group's financial information
has been presented in Pounds Sterling (GBP). Amounts are
rounded to the nearest thousand, unless otherwise
stated.
2. Going
concern
These financial statements have
been prepared on the going concern basis. The Directors have
reviewed KRM22's going concern position taking into account of its
current business activities, budgeted performance and the factors
likely to affect its future development, which are set out in this
Annual Report, and include KRM22's objectives, policies and
processes for managing its capital, its financial risk management
objectives and its exposure to credit and liquidity
risks.
The Directors have undertaken a
significant assessment of the cashflow forecast covering a period
of at least twelve months from the date of approval of the
financial statements. Cashflow forecasts have been prepared
based on a range of scenarios including, but not limited to,
existing customer churn at different churn rates, no new contracted
sales revenue, delayed sales and a combination of these different
scenarios.
Having assessed the sensitivity
analysis on cashflows, the key risks to KRM22 remaining a going
concern and not being in breach of the financial covenants
associated with the TT Convertible Loan is existing customers
paying on payment terms and within 45 days of invoice, customer
churn or up to 10%, conversion of some of the sales opportunities
that are currently at contract negotiation stage and maintaining
control of the cost base.
The time to close new customers and
the value of each customer, which are deemed individually as high
value and low volume in nature, is key to the forecast being
achieved and KRM22 continuing to operate within its existing
facilities, this being KRM22's current cash balance and the ability
to drawdown on the remaining funds available through the TT
Convertible Loan. However, even if the forecast is achieved,
there remains a material uncertainty around KRM22 operating within
the financial covenants associated with TT Convertible Loan.
The TT Convertible Loan includes financial covenants, reported at
the end of each quarter, based on the Group's financial performance
and there is a risk that KRM22 breaches the Cash Covenant, which
requires KRM22 to retain a minimum amount of cash, on the 31
December 2024 and 31 March 2025 measurement dates. Failure to
comply with a financial covenant will result in an Event of Default
which may result in TT withdrawing the TT Convertible Loan with all
accrued amounts becoming immediately due and payable which would
result in KRM22 becoming insolvent.
The Board have received a letter of
support from TT that they would be willing to enter into
discussions with KRM22 around amending the terms of the TT
Convertible Loan to ensure that KRM22 does not breach the Cash
Covenant. Amendments could include, but are not limited to,
reducing the value of the Cash Covenant at each measurement date so
that KRM22's cash exceeds the minimum cash requirement on each
measurement date, and deferring the accrued interest payments that
are due on 31 December 2024 and 31 March 2025 to 30 June 2025 and
30 September 2025 respectively. If the TT Convertible Loan
was not amened, KRM22 would be obliged to seek alternative
resolution including implementing extensive cost reduction
measures.
The Directors have concluded that
the circumstances set forth above indicates the existence of a
material uncertainty that may cast significant doubt on KRM22's
ability to continue as a going concern. However, given
KRM22's forecast, visible sales pipeline, working capital needs and
letter of support from TT, the Directors have considered it
appropriate to prepare the financial statements on a going concern
basis and the financial statements do not include the adjustments
that would be required if KRM22 were unable to continue as a going
concern.
3. Segmental
reporting
The Board of Directors, as the
chief operating decision maker in accordance with IFRS 8 Operating
Segments, has determined that KRM22 have identified two areas of
risk management as operating segments, together with a third
segment where the two areas of risk management are not easily
separable, however for reporting purposes into a single global
business unit and operates as a single operating segment, as the
nature of services delivered are common.
The internal management accounting
information has been prepared in accordance with IFRS but has a
non-GAAP 'Adjusted EBITDA' as a profit measure for the overall
group. This amount is reported on the face of the income
statement.
KRM22's revenue from external
customers and information about its non-current assets, excluding
deferred tax, by geography is detailed below:
|
|
Revenue
2023
|
Non-current
assets
2023
|
Revenue
2022
|
Non-current
assets
2022
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
|
UK
|
1,906
|
2,109
|
1,712
|
2,694
|
|
Europe
|
792
|
1,466
|
716
|
1,955
|
|
USA
|
2,215
|
2,203
|
1,520
|
3,141
|
|
Rest of
world
|
353
|
-
|
325
|
1
|
|
Total
|
5,266
|
5,778
|
4,273
|
7,791
|
The Directors consider that the
business has two areas of risk management: Trading Risk and
Corporate Risk as is described in the Strategic Report.
Within these segments, there are two revenue streams with different
characteristics, which are generated from the same assets and cost
base.
For the year ended 31 December
2023, no customer generated more than 10% of total revenue
recognised in the year. For the year ended 31 December 2022,
one customer, reported within the UK segment, generated more than
10% of total revenue and the total revenue received from this
customer was £0.5m.
Non-current assets include goodwill
and intangible assets recognised on consolidation and are
classified by reference to the geographical location of the KRM22
group company which initially acquired the acquiree.
Recurring revenue is recognised
over the period of time and non-recurring revenue is recognised at
a point in time.
|
|
2023
|
2022
|
|
|
£'000
|
£'000
|
|
Recurring
revenue
|
4,769
|
3,945
|
|
Non-recurring revenue
|
497
|
328
|
|
Total
revenue
|
5,266
|
4,273
|
|
|
2023
|
2022
|
2020
|
|
|
£'000
|
£'000
|
£'000
|
|
Trading
Risk
|
2,487
|
1,867
|
420
|
|
Corporate
Risk
|
2,593
|
2,258
|
2,476
|
|
Multiple
Risk
|
72
|
148
|
|
|
TT
platform
|
114
|
-
|
1,673
|
|
Total
|
5,266
|
4,273
|
4,594
|
4. Loss per
share
Basic earnings per share is
calculated by dividing the loss attributable to the equity holders
of KRM22 by the weighted average number of shares in issue during
the year.
KRM22 has dilutive ordinary shares,
this being warrants, restricted stock awards and share options
granted to employees. As KRM22 has incurred a loss in the
year, the diluted loss per share is the same as the basic earnings
per share as the loss has an anti-dilutive effect.
|
|
2023
|
2022
|
|
|
£'000
|
£'000
|
|
Loss for
the year attributable to equity holders of the parent
|
(4,619)
|
(3,101)
|
|
Basic
weighted average number of shares in issue
|
35,666,336
|
35,666,336
|
|
Diluted
weighted average number of shares in issue
|
46,492,491
|
46,671,529
|
|
Basic and diluted loss per
share
|
(13.0p)
|
(8.7p)
|
5. Intangible
assets
|
|
Goodwill on
consolidation
£'000
|
Acquired
software
&
related
assets
£'000
|
Capitalised
development
costs
£'000
|
Total
£'000
|
Cost
|
|
|
|
|
|
At 1 January 2023
|
|
8,053
|
2,944
|
3,564
|
14,561
|
Additions
|
|
-
|
-
|
1,105
|
1,105
|
Foreign
exchange movements
|
|
(246)
|
(57)
|
(20)
|
(323)
|
At 31
December 2023
|
|
7,807
|
2,887
|
4,649
|
15,343
|
Accumulated
amortisation
|
|
|
|
|
|
At 1
January 2023
|
|
2,886
|
1,976
|
2,288
|
7,150
|
Amortisation for the year
|
|
-
|
228
|
826
|
1,054
|
Impairment
charge for the year
|
|
1,497
|
-
|
96
|
1,593
|
Foreign
exchange movements
|
|
(92)
|
19
|
(2)
|
(75)
|
At 31
December 2023
|
|
4,291
|
2,223
|
3,208
|
9,722
|
|
|
|
|
|
|
At 31
December 2022
|
|
5,167
|
968
|
1,276
|
7,411
|
|
|
|
|
|
|
At 31 December
2023
|
|
3,516
|
664
|
1,441
|
5,621
|
6. Events after the
reporting date
On 7 March 2024, Dan Carter was
appointed CEO of the Company, whilst Stephen Casner, a founder
director and former CEO of the Company, resigned from KRM22.
In addition, Keith Todd relinquished his role as Executive
Chairman, whilst remaining an Executive Director of the Company and
Garry Jones succeeded Keith Todd of Non-Executive Chairman of the
Company.
On 10 April 2024, the Company
issued 140,187 new ordinary shares of 10 pence each in the Company
at a price of 85 pence per Ordinary Share as consideration for a
partial settlement of the deferred consideration payable in respect
of the historical acquisition of Object+ Holding B.V.
7. Cautionary
statement
This document contains certain
forward-looking statements relating to KRM22. KRM22 considers
any statements that are not historical facts as "forward-looking
statements". They relate to events and trends that are
subject to risk and uncertainty that may cause actual results and
the financial performance of the Company to differ materially from
those contained in any forward-looking statement. These
statements are made by the Directors in good faith based on
information available to them and such statements should be treated
with caution due to the inherent uncertainties, including both
economic and business risk factors, underlying any such
forward-looking information.